Effect of a 5-Day Regimen on Peripheral Stem Cell Mobilization

Study Title
Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants
Teva Identifier
TV44688-ONC-30054
ClinicalTrials.gov Identifier
NCT03029000
Study Status
Terminated
Trial Condition(s)
Healthy Participants
Interventions
Drug: Tbo-filgrastim

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 60 Years
Trial Duration
August 2, 2017 - October 30, 2017
Phase
Phase 3

Study Type

Interventional